Repro India Ltd

NSE: REPRO BSE: 532687

₹354.30

(1.54%)

Wed, 17 Jun 2026, 09:08 am

MTF 5xInvest in Repro India Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)514.07

PE Ratio0

Dividend0

Commercial Services

Commercial Printing/Forms

24.5K

Repro India News

Repro India completes property sale for ₹282 crore

Repro India Limited has completed the sale of leasehold rights for a non-operational property in Navi Mumbai to STT Global Data Centres for ₹282 crore. The transaction was finalized on May 22, 2026, following the execution of the Assignment Deed. Proceeds will be used to reduce debt and strengthen the balance sheet.

22 May 2026

companies

Repro India board meets May 29

Repro India Limited will hold a board meeting on May 29, 2026, to consider audited financial results for Q4 and FY26. The trading window remains closed until 48 hours after results are declared.

21 May 2026

companies

Repro India Files Q4FY26 SEBI Compliance Certificate

Repro India Limited submitted its quarterly compliance certificate under SEBI Depositories Regulations for the quarter ended March 31, 2026, confirming no dematerialisation requests were received during the period.

07 Apr 2026

companies

Repro India Forms US Subsidiary Repro Books Inc

Repro India Limited announces incorporation of step-down subsidiary Repro Books Inc. in Delaware, USA on March 05, 2026 for books manufacturing and distribution business.

06 Mar 2026

co actions results

Repro India Posts Q3FY26 Profit, Approves ₹282 Cr Asset Sale

Repro India Limited reported consolidated profit of ₹75 lakhs for Q3FY26 and approved sale of non-operational Mahape property for ₹282 crores to STT Global Data Centres.

13 Feb 2026

co actions results

Showing 1–5 of 18

Rows per page:

Market Current News

S&P 500 Edges Lower at Market Open

The S&P 500 slipped 2.39 points, or 0.03%, to 7,551.90 shortly after the market open, reflecting a marginal decline in early trading.

16 Jun 2026

global

FERMENTA BIOTECH LIMITED

Fermenta Biotech seeks NSE listing

Fermenta Biotech applied to NSE on June 16, 2026, for direct listing of equity shares to enable trading on the exchange platform.

16 Jun 2026

ipo

Avience Biomedicals IPO opens June 18

Avience Biomedicals Limited plans an SME IPO to fund ₹15.96 crore capex. Revenue surged 88.81% in FY25, but cash flow turned negative.

16 Jun 2026

ipo

Riyaasat Lifestyle files DRHP for SME IPO

Riyaasat Lifestyle Limited filed its Draft Red Herring Prospectus for an SME IPO to raise funds for expansion. The ethnic wear company reported revenue of ₹27.87 Cr for the 10 months ended Jan 2026.

16 Jun 2026

ipo

Anubhav Plast files DRHP for SME IPO

Anubhav Plast Limited filed its DRHP for an SME IPO to raise ₹15.95 crore. Net profit surged 8x to ₹6 crore in FY25.

16 Jun 2026

ipo

Showing 1–5 of 93889

Rows per page: